Study of Normal Conditions of Use, Dosing, and Safety of Intravenous (IV) Administration of Vernakalant (MK-6621-049)

NCT01370629 · clinicaltrials.gov ↗

COMPLETED

Status

2015

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Vernakalant

Sponsor

Correvio International Sarl